Legislation introduced by the European Medicines Agency (EMEA) has had a big impact on the processes involved in approving drugs for children. SMi’s 4th annual Paediatric Clinical Trials conference aims to explore the latest developments and regulatory changes in this crucial area. By attending you will gain valuable insights into the evolving regulatory framework for paediatric trials.

Presentations Include:

• IMPACT OF US AND EU PAEDIATRIC LEGISLATION ON DRUG DEVELOPMENT
Klaus Rose, Head of Paediatrics, Roche

• FUNTIONAL AND QUALITY OF LIFE EVALUATION IN PAEDIATRIC TRIALS
Rodrigo Escobar, Medical Advisor, European Team Physician, Eli Lilly

• PAEDIATRIC TRIALS: HOW TO ADDRESS THE PAEDIATRIC POPULATION IN DRUG EVALUATION
Karl-Heinz Huemer, PDCO Member and Clinical Assessor, Austrian Agency for Health and Food Safety


PLUS A HALF DAY PRE-CONFERENCE WORKSHOP
Preparing a Paediatric Investigation Plan
27th January 2010, Crowne Plaza Hotel - St James, London, UK
Hosted by Dr. Klaus Rose, Global Head of Paediatrics, Roche Pharmaceuticals

Academic and Group Discounts Available!!